Both in Pharmaceuticals
Acadia Pharmaceuticals vs Tango Therapeutics
Over the past year ACAD returned −5.4% and TNGX returned +157.2%; their daily moves had a correlation of 0.17.
ACAD −5.4% TNGX +157.2%Growth of $1, one year, split-adjusted
| Metric | ACAD | TNGX |
|---|---|---|
| Price | $19.80 | $23.53 |
| Market cap | $3.41B | $3.97B |
| Today | +3.56% | +6.76% |
| 1 month | −27.4% | +8.2% |
| 6 months | −10.4% | −10.8% |
| Year to date | −25.9% | +165.6% |
| 1 year | −4.0% | +156.6% |
| Revenue growth (YoY) | +16.4% | −100.0% |
| Gross margin | 90.8% | — |
| Net margin | 10.2% | — |
| P/E (TTM) | 9.0× | — |
| Price / sales | 3.0× | 73.7× |
| Net cash | $956.5M | $1.01B |
| Dividend yield | — | — |
| Volatility (60d) | 47.4% | 62.0% |
| Short % of float | 6.5% | 31.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).